Non-Current Assets
Equity Method Investments
AbbVie Equity Method Investments increased by 55.8% to $268.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.9%, from $279.00M to $268.00M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows relatively stable performance with a -1.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025
How to read this metric
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
Detailed definition
These are investments in entities where the company exercises significant influence but does not have full control. The...
Peer comparison
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
Metric ID:
equity_method_investmentsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $118.00M | $132.00M | $277.00M | $147.00M | $148.00M | $143.00M | $241.00M | $115.00M | $124.00M | $131.00M | $304.00M | $161.00M | $160.00M | $153.00M | $279.00M | $157.00M | $166.00M | $172.00M | $268.00M |
| QoQ Change | — | +11.9% | +109.8% | -46.9% | +0.7% | -3.4% | +68.5% | -52.3% | +7.8% | +5.6% | +132.1% | -47.0% | -0.6% | -4.4% | +82.4% | -43.7% | +5.7% | +3.6% | +55.8% |
| YoY Change | — | — | — | — | +25.4% | +8.3% | -13.0% | -21.8% | -16.2% | -8.4% | +26.1% | +40.0% | +29.0% | +16.8% | -8.2% | -2.5% | +3.8% | +12.4% | -3.9% |
Range$115.00M – $304.00M
CAGR+20.0%
Avg YoY Growth+5.9%
Median YoY Growth+3.8%
Current Streak3 quarters growth
Equity Method Investments at Other Companies
Frequently Asked Questions
- What is AbbVie's equity method investments?
- AbbVie (ABBV) reported equity method investments of $268.00M in Q4 2025.
- How has AbbVie's equity method investments changed year-over-year?
- AbbVie's equity method investments decreased by 3.9% year-over-year, from $279.00M to $268.00M.
- What is the long-term trend for AbbVie's equity method investments?
- Over 5 years (2020 to 2025), AbbVie's equity method investments has grown at a -1.8% compound annual growth rate (CAGR), from $293.00M to $268.00M.
- What does equity method investments mean?
- The value of investments in other companies where the firm has significant influence but not total control.